Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction - Ludwig,M.; Felberbaum,R.E.; Devroey,P. (Arch Gynecol Obstet, 2000)